AstraZeneca PLC

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB0009895292
GBP
118.96
0.46 (0.39%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
11,461.36
11,346.40
11,657.34
11,263.93
10,829.16
10,789.99
11,619.22
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
11,461.36
11,346.40
11,657.34
11,263.93
10,829.16
10,789.99
11,619.22
Raw Material Cost
3,031.48
2,712.66
3,241.62
2,940.74
2,688.38
2,541.06
3,750.05
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
324.08
291.68
363.94
321.81
328.84
277.13
334.74
Selling and Distribution Expenses
3,383.13
3,008.78
3,404.79
3,040.84
2,994.74
2,872.20
3,494.12
Other Expenses
240.42
227.77
244.08
231.12
225.92
217.58
245.17
Total Expenditure (Excl Depreciation)
9,142.87
8,290.85
9,451.15
8,614.60
8,271.12
7,866.18
10,030.56
Operating Profit (PBDIT) excl Other Income
2318.5
3055.5
2206.2
2649.3
2558
2923.8
1588.7
Other Income
172.84
194.45
177.46
129.02
104.87
157.23
127.97
Operating Profit (PBDIT)
3,928.48
4,263.80
3,519.84
3,926.92
3,703.35
4,100.64
3,540.15
Interest
324.08
291.68
363.94
321.81
328.84
277.13
334.74
Exceptional Items
-74.50
-44.53
-42.86
-58.58
15.73
-96.88
-78.03
Gross Profit (PBDT)
8,429.88
8,633.74
8,415.72
8,323.19
8,140.79
8,248.93
7,869.17
Depreciation
1,437.14
1,013.81
1,136.18
1,148.56
1,040.44
1,019.60
1,823.53
Profit Before Tax
2,092.76
2,913.79
1,976.85
2,397.97
2,349.80
2,707.03
1,303.86
Tax
216.80
618.23
225.58
525.71
508.61
381.95
129.53
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,867.76
2,285.90
1,749.02
1,878.19
1,835.20
2,315.54
1,170.43
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,867.76
2,285.90
1,749.02
1,878.19
1,835.20
2,315.54
1,170.43
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.75
0.74
2.26
1.48
-1.50
3.97
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,868.51
2,286.65
1,751.27
1,879.67
1,833.70
2,319.52
1,170.43
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.19
0.19
0.19
0.19
0.18
0.19
0.2
Reserves
37,894.14
35,893.68
36,182.30
34,085.79
32,633.27
31,794.69
32,566.27
Earnings per share (EPS)
1.2
1.46
1.12
1.2
1.18
1.48
0.75
Diluted Earnings per share
1.2
1.46
1.12
1.2
1.18
1.48
0.75
Operating Profit Margin (Excl OI)
20.23%
26.93%
18.93%
23.52%
23.62%
27.1%
13.67%
Gross Profit Margin
30.8%
34.62%
26.7%
31.49%
31.31%
34.54%
26.92%
PAT Margin
16.3%
20.15%
15.0%
16.67%
16.95%
21.46%
10.07%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2026 is 5.84% vs 5.61% in Jun 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2026 is 1.90% vs 20.01% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is 4.37% vs 10.23% in Jun 2025

stock-summary

Interest

YoY Growth in quarter ended Jun 2026 is -1.43% vs -6.35% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025

Compare Quarterly Results Of AstraZeneca PLC With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(GBP)
Change(%)
Net Sales
11,461.36
8,409.00
3,052.36
36.30%
Other Operating Income
0.00
0.00
0.00
Total Operating income
11,461.36
8,409.00
3,052.36
36.30%
Raw Material Cost
3,031.48
2,098.00
933.48
44.49%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
324.08
182.00
142.08
78.07%
Selling and Distribution Expenses
3,383.13
2,192.00
1,191.13
54.34%
Other Expenses
240.42
153.90
86.52
56.22%
Total Expenditure (Excl Depreciation)
9,142.87
6,011.00
3,131.87
52.10%
Operating Profit (PBDIT) excl Other Income
2,318.50
2,398.00
-79.50
-3.32%
Other Income
172.84
550.00
-377.16
-68.57%
Operating Profit (PBDIT)
3,928.48
3,171.00
757.48
23.89%
Interest
324.08
182.00
142.08
78.07%
Exceptional Items
-74.50
-2,409.00
2,334.50
96.91%
Gross Profit (PBDT)
8,429.88
6,311.00
2,118.88
33.57%
Depreciation
1,437.14
223.00
1,214.14
544.46%
Profit Before Tax
2,092.76
357.00
1,735.76
486.21%
Tax
216.80
-199.00
415.80
208.94%
Provisions and contingencies
0
0
0.00
Profit After Tax
1,867.76
435.00
1,432.76
329.37%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,867.76
435.00
1,432.76
329.37%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.75
118.00
-117.25
-99.36%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,868.51
553.00
1,315.51
237.89%
Equity Capital
0
0
0.00
Face Value
0.19
0.31
0.00
Reserves
37,894.14
17,645.00
20,249.14
114.76%
Earnings per share (EPS)
1.20
0.11
1.09
990.91%
Diluted Earnings per share
1.20
0.11
1.09
990.91%
Operating Profit Margin (Excl OI)
20.23%
28.52%
0.00
-8.29%
Gross Profit Margin
30.80%
6.90%
0.00
23.90%
PAT Margin
16.30%
5.17%
0.00
11.13%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,146.14 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 1.01% vs -2.67% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 5.84% vs 5.61% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 186.85 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -18.28% vs 30.57% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 1.90% vs 20.01% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 375.56 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -7.71% vs 21.75% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 4.37% vs 10.23% in Jun 2025

Quarterly - Interest
Interest 32.41 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 11.11% vs -19.84% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -1.43% vs -6.35% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.23%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025